According to Nova one advisor, the U.S Medical Aesthetic Devices Market Size was valued at USD 16.75 billion in 2022 and is predicted to be worth USD 42.85 billion by 2032, with a CAGR of 9.80% from 2023 to 2032.
Key Takeaways:
Medical Aesthetic Devices are used to overcome flaws in a person's physical appearance. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) estimates that in the United States in 2021, 1.4 million surgical and non-surgical operations were carried out. The top 5 cosmetic surgical procedure in the United States includes Facelift surgeries, Liposuction, Breast Augmentation, Nose reshaping, and eyelid surgery. The demand for aesthetic treatment in developing countries is growing due to the urge to look young and fit.
The aesthetic method such as liposuction, nose reshaping, and Botox injection are gaining consumer attention. Skin-tightening and non-invasive fat technologies have recently established out a new niche in the medical aesthetics market. The key factors enhancing the growth of the U.S. Aesthetic Medical Device market are a surge in the prevalence of facial deformities and congenital teeth, enhancement in demand for non-invasive surgeries, an increase in the number of cosmetic surgeries, and advancement in aesthetic devices.
Report Scope of the U.S Medical Aesthetic Devices Market
Report Coverage |
Details |
Market Size in 2023 |
USD 18.35 Billion |
Market Size by 2032 |
USD 42.85 Billion |
Growth Rate from 2023 to 2032 |
CAGR of 9.80% |
Base Year |
2022 |
Forecast Period |
2023 to 2032 |
Segments Covered |
By Type of Device, By Application, By End User |
Segments Insight
Type of Device Insights
Based on the type of device, the U.S. Aesthetic Medical Device Market is segmented into Energy-based Aesthetic Devices and Non-energy-based Aesthetic Devices. The Energy-based Aesthetic Device is further segmented into Laser-based Aesthetic Devices, Radiofrequency (RF)-based Aesthetic Devices, Light-based Aesthetic Devices, and Ultrasound Aesthetic devices.
The Non-energy-based aesthetic device is segmented into botulinum toxin, dermal fillers and aesthetic threads, microdermabrasion, and others. In 2022 the implants (non-energy based) sector accounted for 79.40% of the aesthetic medicine market, because of rising demand for procedures like breast augmentation and face surgeries like rhinoplasty and blepharoplasty. In June 2020, JUVÉDERM® VOLUMATM XC of Allergan Aesthetics, a subsidiary of AbbVie Inc. (U.S.), was granted approval by the FDA for the augmentation of the chin area in people over the age of 21.
Application Insights
Based on application, the largest market share in 2022 is held by the skin resurfacing and tightening segment. This is due to the large population undergoing cosmetic treatment which includes skin resurfacing, and diminishing fine lines, wrinkles, and dark spots. The face aesthetics segment's revenue in 2020 was primarily driven by the growing demand for non-invasive cosmetic treatments and facial aesthetic operations. During the projected period, the market's feminine rejuvenation category is anticipated to grow at the largest CAGR. The most effective procedure for fat removal is liposuction. It removes up to 5 liters of fat from the procedure.
For instance, according to the American Society of Plastic Surgeons (ASPS), liposuction ranked second among procedures performed in the U.S. following breast augmentation, with 211,067 procedural volumes in 2020. During the projection period, non-surgical skin tightening is anticipated to see considerable market growth of 15.0%. This is due to the body's synthesis of collagen increasing with age but elastin decreasing, which causes fine lines and dull, sagging skin to appear.
End-User Insights
Based on the end-user, the largest share of the medical aesthetic market is estimated to be accounted for by the hospitals and clinics segment, in 2022. The increased demand for minimally invasive cosmetic operations and the emergence of medical spas and clinics with infrastructure fully equipped with technologically advanced instruments/devices and skilled professionals are the two main drivers of this segment's growth.
Some of the prominent players in the U.S Medical Aesthetic Devices Market include:
Segments Covered in the Report
This report forecasts revenue growth and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S Medical Aesthetic Devices market.
By Type of Device
By Application
By End User
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on US Medical Aesthetic Devices Market
5.1. COVID-19 Landscape: US Medical Aesthetic Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. US Medical Aesthetic Devices Market, By Type of Device
8.1. US Medical Aesthetic Devices Market, by Type of Device, 2022-2032
8.1.1 Energy-based Aesthetic Device
8.1.1.1. Market Revenue and Forecast (2022-2032)
8.1.2. Non-energy-based Aesthetic Device
8.1.2.1. Market Revenue and Forecast (2022-2032)
Chapter 9. US Medical Aesthetic Devices Market, By Application
9.1. US Medical Aesthetic Devices Market, by Application, 2022-2032
9.1.1. Skin Resurfacing and Tightening
9.1.1.1. Market Revenue and Forecast (2022-2032)
9.1.2. Body Contouring and Cellulite Reduction
9.1.2.1. Market Revenue and Forecast (2022-2032)
9.1.3. Hair Removal
9.1.3.1. Market Revenue and Forecast (2022-2032)
9.1.4. Tattoo Removal
9.1.4.1. Market Revenue and Forecast (2022-2032)
9.1.5. Breast Augmentation
9.1.5.1. Market Revenue and Forecast (2022-2032)
9.1.6. Other Applications
9.1.6.1. Market Revenue and Forecast (2022-2032)
Chapter 10. US Medical Aesthetic Devices Market, By End User
10.1. US Medical Aesthetic Devices Market, by End User, 2022-2032
10.1.1. Hospital & Clinics
10.1.1.1. Market Revenue and Forecast (2022-2032)
10.1.2. Home Settings
10.1.2.1. Market Revenue and Forecast (2022-2032)
Chapter 11. US Medical Aesthetic Devices Market, Regional Estimates and Trend Forecast
11.1. U.S.
11.1.1. Market Revenue and Forecast, by Type of Device (2022-2032)
11.1.2. Market Revenue and Forecast, by Application (2022-2032)
11.1.3. Market Revenue and Forecast, by End User (2022-2032)
Chapter 12. Company Profiles
12.1. Cynosure
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Alma Lasers
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Lumenis Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Bausch Health Companies Inc. (Solta Medical Inc.)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Abbvie
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Lumenis Ltd.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Dentsply Sirona, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Dentsply Sirona, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. PhotoMedex, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Straumann
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms